| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | -21.2% |
| R&D Expense | $704K | -22.1% |
| SG&A Expense | $13.0M | +32.9% |
| Operating Income | -$27.3M | -22.4% |
| Interest Expense | $304K | +4.4% |
| Pre-tax Income | -$27.6M | -24.4% |
| Income Tax | $0 | — |
| Net Income | -$27.6M | -24.4% |
| EPS (Basic) | -$7.17 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | -91.9% |
| Accounts Receivable | $1.2M | +260.8% |
| Inventory | $1.7M | -23.9% |
| Current Assets | $11.6M | -89.0% |
| Total Assets | $187.6M | -12.3% |
| Current Liabilities | $14.6M | -5.6% |
| Long-term Debt | $8.5M | -2.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.2M | -15.4% |
| Capital Expenditures | $68.9M | +2.1% |
| Investing Cash Flow | -$68.9M | -300.6% |
| Financing Cash Flow | -$308K | -89.9% |
| Free Cash Flow | -$93.1M | -5.2% |
| — |
| EPS (Diluted) | -$7.17 | -2212.9% |
| Total Liabilities |
| $22.5M |
| +2.8% |
| Stockholders' Equity | $165.0M | -14.0% |